Thus, vaccination with alpha-galactosylceramide-loaded A20 lymphoma cells elicited effective antitumor immunity against tumor challenge, and depletion as well as adoptive transfer studies revealed an exclusive role of conventional CD4+, but not CD8+, T cells in mediating antitumor immunity (34). Here, CD8A is linked to neoplasm.